Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Wakelin-Smith

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Clinical Pharmacology and Therapeutics|November 6, 2025
Evolving Standards: Good Clinical Practice Insights from US FDA, MHRA UK, and Health CanadaCheryl Grandinetti, Mandy Budwal-Jagait, Hocine Abid, et al.
Clinical Pharmacology and Therapeutics|August 6, 2021
Tackling Challenging Data Integrity Topics in 2020: Update on Good Clinical Practice Perspectives from the US FDA and MHRA UKNi A Khin, Cheryl Grandinetti, Hayley Dixey, et al.
Bioanalysis|November 30, 2010
2010 white paper on recent issues in regulated bioanalysis & global harmonization of bioanalytical guidanceNatasha Savoie, Fabio Garofolo, Peter van Amsterdam, et al.
Bioanalysis|November 19, 2016
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 2 - Hybrid LBA/LCMS and input from regulatory agencies)An Song, Anita Lee, Fabio Garofolo, et al.
Bioanalysis|October 8, 2016
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV) (Part 1 - small molecules, peptides and small molecule biomarkers by LCMS)Eric Yang, Jan Welink, Stephanie Cape, et al.
Bioanalysis|December 24, 2014
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 3 - LBA and immunogenicity)Lauren Stevenson, Lakshmi Amaravadi, Heather Myler, et al.
Bioanalysis|December 16, 2014
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 1--small molecules by LCMS)Eric Fluhler, Roger Hayes, Fabio Garofolo, et al.
Bioanalysis|December 23, 2014
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 2 - hybrid LBA/LCMS, ELN & regulatory agencies' input)Dawn Dufield, Hendrik Neubert, Fabio Garofolo, et al.
Bioanalysis|October 11, 2013
2013 White Paper on recent issues in bioanalysis: 'hybrid'--the best of LBA and LCMSLauren Stevenson, Fabio Garofolo, Binodh DeSilva, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical Pharmacology and Therapeutics|November 6, 2025
Evolving Standards: Good Clinical Practice Insights from US FDA, MHRA UK, and Health CanadaCheryl Grandinetti, Mandy Budwal-Jagait, Hocine Abid, et al.
Clinical Pharmacology and Therapeutics|August 6, 2021
Tackling Challenging Data Integrity Topics in 2020: Update on Good Clinical Practice Perspectives from the US FDA and MHRA UKNi A Khin, Cheryl Grandinetti, Hayley Dixey, et al.
Bioanalysis|November 30, 2010
2010 white paper on recent issues in regulated bioanalysis & global harmonization of bioanalytical guidanceNatasha Savoie, Fabio Garofolo, Peter van Amsterdam, et al.
Bioanalysis|November 19, 2016
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 2 - Hybrid LBA/LCMS and input from regulatory agencies)An Song, Anita Lee, Fabio Garofolo, et al.
Bioanalysis|October 8, 2016
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV) (Part 1 - small molecules, peptides and small molecule biomarkers by LCMS)Eric Yang, Jan Welink, Stephanie Cape, et al.
Bioanalysis|December 24, 2014
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 3 - LBA and immunogenicity)Lauren Stevenson, Lakshmi Amaravadi, Heather Myler, et al.
Bioanalysis|December 16, 2014
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 1--small molecules by LCMS)Eric Fluhler, Roger Hayes, Fabio Garofolo, et al.
Bioanalysis|December 23, 2014
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 2 - hybrid LBA/LCMS, ELN & regulatory agencies' input)Dawn Dufield, Hendrik Neubert, Fabio Garofolo, et al.
Bioanalysis|October 11, 2013
2013 White Paper on recent issues in bioanalysis: 'hybrid'--the best of LBA and LCMSLauren Stevenson, Fabio Garofolo, Binodh DeSilva, et al.
Pageof 1